Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsallergy-and-immunology

Paeds SAQs · allergy-and-immunology

Anaphylaxis: recognition and emergency management — formative SAQs

Formative SAQs on anaphylaxis: the stepwise emergency management of a four-year-old with peanut anaphylaxis (recognition, IM adrenaline dose and site, adjuncts, observation, discharge package), and the recognition and management of an asthmatic adolescent with food anaphylaxis and no skin signs, including the refractory escalation, tryptase interpretation and the biphasic observation decision.

20 marks30 min5 min readSource-verified ·

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalABP General Pediatrics
Prompt
Anaphylaxis: recognition and emergency management

SAQ 1 (10 marks)

A four-year-old boy with a known peanut allergy develops, ten minutes after eating a biscuit at a party, sudden flushing, lip and tongue swelling, drooling and a wheeze. His mother gives his adrenaline autoinjector into his thigh and calls an ambulance. On arrival he is improving but still has urticaria and mild wheeze. [1]

Question: Outline the immediate and stepwise emergency management of this child, the observation decision, and the discharge package. (10 marks) [3]

Model answer

Recognition and first response (2 marks). This is anaphylaxis under the NIAID/FAAN criteria — acute skin and mucosal involvement (flushing, lip and tongue swelling, urticaria) plus respiratory compromise (drooling suggesting upper-airway oedema, and wheeze). The mother's early adrenaline was exactly right. On arrival, confirm the ABCDE status, continue to lie him flat with legs raised (sit up only if breathing distressed), remove any remaining trigger, and call for the resuscitation team. Up to a fifth of reactions have no skin signs, so the presence of skin signs here makes the diagnosis clear but should never be the reason to delay adrenaline in another child. [1]

Adrenaline — first-line, intramuscular (2 marks). Adrenaline is the decisive drug, given intramuscularly into the anterolateral thigh where absorption is fastest and most reliable. For a four-year-old (under about six years and under thirty kilograms) the dose is 150 micrograms — 0.15 millilitres of the 1 milligram per millilitre concentration, equivalent to the junior autoinjector the mother used. The dose is repeated every five minutes if there is no response. Adrenaline works through its receptor profile: alpha-1 reverses the oedema and the distributive shock, beta-2 bronchodilates and stabilises the mast cell, beta-1 supports the circulation. [3]

Adjuncts (2 marks). Give high-flow oxygen for hypoxia or an oxygen saturation below 94 per cent. Give an intravenous crystalloid bolus of 10 millilitres per kilogram if there is hypotension or poor perfusion, repeating to 20 millilitres per kilogram if needed, because the vasodilation and capillary leak create large fluid deficits. Nebulised salbutamol treats refractory wheeze. An H1 antihistamine relieves urticaria and pruritus; a corticosteroid and an H2 blocker are traditional adjuncts. None of these replaces adrenaline or should delay it — they are for symptom comfort and the historical hope of preventing a biphasic reaction. [3] [4]

Observation and the biphasic reaction (2 marks). Because symptoms can recur one to seventy-two hours after the initial resolution without further allergen exposure — the biphasic reaction — the child cannot simply be sent home. This presentation resolved after a single adrenaline dose with full recovery, so a minimum of around six hours' observation is reasonable, provided the family has good access to emergency care. If the child had needed two or more adrenaline doses, had a refractory or severe course, has asthma, is on a beta-blocker, or has poor access to care, admit overnight. The paediatric repeat-epinephrine cohort evidence supports this severity-graded approach rather than a single blanket duration. [9] [10]

Discharge package (2 marks). Before discharge the child must leave with the prevention package: an adrenaline autoinjector (ideally two), prescribed with a device-matched trainer; a written ASCIA action plan naming the trigger, the dose and the steps, copied to the school or childcare; a referral to the allergy clinic to confirm the trigger with skin-prick and specific-IgE testing and, where indicated, a supervised oral food challenge; and family and school education on strict peanut avoidance, when and how to use the autoinjector, and to call an ambulance immediately and use a second device if there is no response. Sending the child home without this package sets up a recurrent, potentially fatal reaction. [8] [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Sampson HA; Muñoz-Furlong A; Campbell RL; et al Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med, 2006.PMID 16546624
  2. [3]Simons FE; Ardusso LR; Bilò MB; et al World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J, 2011.PMID 23268454
  3. [4]Muraro A; Worm M; Alviani C; et al EAACI guidelines: Anaphylaxis (2021 update). Allergy, 2022.PMID 34343358
  4. [8]Sicherer SH; Simons FER; SECTION ON ALLERGY AND IMMUNOLOGY Epinephrine for First-aid Management of Anaphylaxis. Pediatrics, 2017.PMID 28193791
  5. [9]Lee S; Bellolio MF; Hess EP; et al Predictors of biphasic reactions in the emergency department for patients with anaphylaxis. J Allergy Clin Immunol Pract, 2014.PMID 24811018
  6. [10]Dribin TE; Sampson HA; Zhang Y; et al Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study. Lancet Child Adolesc Health, 2025.PMID 40506197
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAnaphylaxis prevention, action plans and autoinjectors — formative SAQsallergy-and-immunologyNextAntibody deficiencies — formative SAQsallergy-and-immunology